These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 18788018)
21. Pulmonary effects in rats inhaling size-separated chrysotile asbestos fibres or p-aramid fibrils: differences in cellular proliferative responses. Warheit DB; Hartsky MA; Frame SR Toxicol Lett; 1996 Nov; 88(1-3):287-92. PubMed ID: 8920750 [TBL] [Abstract][Full Text] [Related]
22. Biopersistence of rock wool in lungs after short-term inhalation in rats. Kudo Y; Aizawa Y Inhal Toxicol; 2008 Jan; 20(2):139-47. PubMed ID: 18236228 [TBL] [Abstract][Full Text] [Related]
23. The health effects of chrysotile: current perspective based upon recent data. Bernstein DM; Hoskins JA Regul Toxicol Pharmacol; 2006 Aug; 45(3):252-64. PubMed ID: 16814911 [TBL] [Abstract][Full Text] [Related]
24. The health risk of chrysotile asbestos. Bernstein DM Curr Opin Pulm Med; 2014 Jul; 20(4):366-70. PubMed ID: 24811832 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to chrysotile or crocidolite asbestos in a 28-day quantitative inhalation toxicology study. Bernstein DM; Toth B; Rogers RA; Sepulveda R; Kunzendorf P; Phillips JI; Ernst H Toxicol Appl Pharmacol; 2018 Jul; 351():74-92. PubMed ID: 29705295 [TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Berman DW; Crump KS Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078 [TBL] [Abstract][Full Text] [Related]
27. Persistence of natural mineral fibers in human lungs: an overview. Churg A; Wright JL Environ Health Perspect; 1994 Oct; 102 Suppl 5(Suppl 5):229-33. PubMed ID: 7882939 [TBL] [Abstract][Full Text] [Related]
28. Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat. Tanaka S; Choe N; Hemenway DR; Zhu S; Matalon S; Kagan E J Clin Invest; 1998 Jul; 102(2):445-54. PubMed ID: 9664087 [TBL] [Abstract][Full Text] [Related]
29. Chrysotile biopersistence in the lungs of persons in the general population and exposed workers. Langer AM; Nolan RP Environ Health Perspect; 1994 Oct; 102 Suppl 5(Suppl 5):235-9. PubMed ID: 7882940 [TBL] [Abstract][Full Text] [Related]
30. Long-term instillation to four natural representative chrysotile of China induce the inactivation of P53 and P16 and the activation of C-JUN and C-FOS in the lung tissues of Wistar rats. Luo Y; Deng J; Cui Y; Li T; Bai J; Huang L; Sun Y; Dong F; Zhang Q Toxicol Lett; 2020 Oct; 333():140-149. PubMed ID: 32755622 [TBL] [Abstract][Full Text] [Related]
31. Lung injury and expression of p53 and p16 in Wistar rats induced by respirable chrysotile fiber dust from four primary areas of China. Zeng Y; Cui Y; Ma J; Huo T; Dong F; Zhang Q; Deng J; Zhang X; Yang J; Wang Y Environ Sci Pollut Res Int; 2018 Aug; 25(23):22389-22399. PubMed ID: 28963651 [TBL] [Abstract][Full Text] [Related]
33. Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers. Berry G Inhal Toxicol; 1999 Feb; 11(2):111-30. PubMed ID: 10380162 [TBL] [Abstract][Full Text] [Related]
34. Fiber localization and its relationship to lung reaction in rats after chronic inhalation of chrysotile asbestos. Pinkerton KE; Pratt PC; Brody AR; Crapo JD Am J Pathol; 1984 Dec; 117(3):484-98. PubMed ID: 6095671 [TBL] [Abstract][Full Text] [Related]
35. Chamber for testing asbestos-containing products: validation and testing of a re-created chrysotile-containing joint compound. Sheehan PJ; Brorby GP; Berman DW; Bogen KT; Holm SE Ann Occup Hyg; 2011 Aug; 55(7):797-809. PubMed ID: 21795244 [TBL] [Abstract][Full Text] [Related]
36. Pathogenicity of a special-purpose glass microfiber (E glass) relative to another glass microfiber and amosite asbestos. Cullen RT; Searl A; Buchanan D; Davis JM; Miller BG; Jones AD Inhal Toxicol; 2000 Oct; 12(10):959-77. PubMed ID: 10989371 [TBL] [Abstract][Full Text] [Related]
37. Chrysotile biopersistence: the misuse of biased studies. Pezerat H Int J Occup Environ Health; 2009; 15(1):102-6. PubMed ID: 19267128 [TBL] [Abstract][Full Text] [Related]
38. Toxicological and epidemiological studies on effects of airborne fibers: coherence and public [corrected] health implications. Lippmann M Crit Rev Toxicol; 2014 Sep; 44(8):643-95. PubMed ID: 25168068 [TBL] [Abstract][Full Text] [Related]
39. Health implications of atmospheric aerosols from asbestos-bearing road pavements traditionally used in Southern Brazil. Godoi RHM; Gonçalves SJ; Sayama C; Polezer G; Reis Neto JM; Alföldy B; Van Grieken R; Riedi CA; Yamamoto CI; Godoi AFL; Bencs L Environ Sci Pollut Res Int; 2016 Dec; 23(24):25180-25190. PubMed ID: 27680005 [TBL] [Abstract][Full Text] [Related]
40. Chronic inhalation of short asbestos: lung fiber burdens and histopathology for monkeys maintained for 11.5 years after exposure. Stettler LE; Sharpnack DD; Krieg EF Inhal Toxicol; 2008 Jan; 20(1):63-73. PubMed ID: 18236224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]